Harrison.ai will add the AI tools of AIRAmed, Koios Medical, Lunit, and Nanox AI to its Open Platform ecosystem.
AIRAmed's AIRAscore assesses brain volumes on MRI scans. The Koios decision-support platform supports breast and thyroid cancer diagnosis using ultrasound. Lunit's tools span from risk prediction and early detection to precision oncology. Nanox supports the implementation of preventive imaging.
Open Platform is designed to give healthcare organizations access to AI solutions across x-ray, CT, MRI, mammography, and ultrasound without marketplace markups, the company said, noting the platform's open architecture model with vendor-neutral interfaces to PACS, RIS, and EHR systems.
Harrison.ai's offerings are live across more than 1,000 healthcare sites worldwide, according to the company. Open Platform launched in 2025.
